Middle East Genome Editing Market (2025 - 2033) Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, ZFN), By Delivery Method (Ex Vivo. In Vivo), By Application, By Mode (Contract, In-house), By End Use, By Country, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Technology Segment
                        1.2.2. Delivery Method Segment
                        1.2.3. Application Segment
                        1.2.4. Mode Segment
                        1.2.5. End Use Segment
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Market Model
                        1.7.1. Commodity Flow Analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. Middle East Genome Editing Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Widespread adoption of CRISPR technologies
                            3.2.1.2. National genome programs boosting regional research
                        3.2.2. Market restraint analysis
                            3.2.2.1. Challenges concerning clinical translation
                            3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
                    3.3. Middle East Genome Editing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
Chapter 4. Middle East Genome Editing Market: Technology Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Middle East Genome Editing Market Technology Movement Analysis
                    4.3. Middle East Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
                    4.4. (CRISPR)/Cas9
                        4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
                    4.5. TALENs/MegaTALs
                        4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
                    4.6. ZFN
                        4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
                    4.7. Meganuclease
                        4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
                    4.8. Others
                        4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East Genome Editing Market: Delivery Method Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Middle East Genome Editing Market Delivery Method Movement Analysis
                    5.3. Middle East Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
                    5.4. Ex Vivo
                        5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
                    5.5. In Vivo
                        5.5.1. In vivo market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East Genome Editing Market: Application Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Middle East Genome Editing Market Application Movement Analysis
                    6.3. Middle East Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    6.4. Genetic Engineering
                        6.4.1. Genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.2. Cell Line Engineering
                            6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.3. Animal Genetic Engineering
                            6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.4. Plant Genetic Engineering
                            6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.5. Others
                            6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
                    6.5. Clinical Applications
                        6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
                        6.5.2. Diagnostics Development
                            6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
                        6.5.3. Therapy Development
                            6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East Genome Editing Market: Mode Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Middle East Genome Editing Market Mode Movement Analysis
                    7.3. Middle East Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
                    7.4. Contract
                        7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
                    7.5. In-house
                        7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Middle East Genome Editing Market: End Use Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. Middle East Genome Editing Market End Use Movement Analysis
                    8.3. Middle East Genome Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    8.4. Biotechnology and Pharmaceutical Companies
                        8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
                    8.5. Academic and Government Research Institutes
                        8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
                    8.6. Contract Research Organizations
                        8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Middle East Genome Editing Market: Country Estimates & Trend Analysis
                    9.1. Country Market Share Analysis, 2024 & 2033
                    9.2. Country Market Dashboard
                    9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
                    9.4. Middle East
                        9.4.1. Saudi Arabia
                            9.4.1.1. Key country dynamics
                            9.4.1.2. Competitive scenario
                            9.4.1.3. Regulatory landscape
                            9.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
                        9.4.2. UAE
                            9.4.2.1. Key country dynamics
                            9.4.2.2. Competitive scenario
                            9.4.2.3. Regulatory landscape
                            9.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
                        9.4.3. Kuwait
                            9.4.3.1. Key country dynamics
                            9.4.3.2. Competitive scenario
                            9.4.3.3. Regulatory landscape
                            9.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
                        9.4.4. Qatar
                            9.4.4.1. Key country dynamics
                            9.4.4.2. Competitive scenario
                            9.4.4.3. Regulatory landscape
                            9.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
                        9.4.5. Oman
                            9.4.5.1. Key country dynamics
                            9.4.5.2. Competitive scenario
                            9.4.5.3. Regulatory landscape
                            9.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
                        9.4.6. Rest of Middle East
                            9.4.6.1. Key country dynamics
                            9.4.6.2. Competitive scenario
                            9.4.6.3. Regulatory landscape
                            9.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Company/Competition Categorization
                    10.2. Strategy Mapping
                    10.3. Company Market Position Analysis, 2024
                    10.4. Company Profiles/Listing
                        10.4.1. Merck KGaA
                            10.4.1.1. Company overview
                            10.4.1.2. Financial performance
                            10.4.1.3. Product benchmarking
                            10.4.1.4. Strategic initiatives
                        10.4.2. Takara Bio Inc.
                            10.4.2.1. Company overview
                            10.4.2.2. Financial performance
                            10.4.2.3. Product benchmarking
                            10.4.2.4. Strategic initiatives
                        10.4.3. Revvity, Inc.
                            10.4.3.1. Company overview
                            10.4.3.2. Financial performance
                            10.4.3.3. Product benchmarking
                            10.4.3.4. Strategic initiatives
                        10.4.4. Danaher Corporation
                            10.4.4.1. Company overview
                            10.4.4.2. Financial performance
                            10.4.4.3. Product benchmarking
                            10.4.4.4. Strategic initiatives
                        10.4.5. GenScript
                            10.4.5.1. Company overview
                            10.4.5.2. Financial performance
                            10.4.5.3. Product benchmarking
                            10.4.5.4. Strategic initiatives
                        10.4.6. New England Biolabs
                            10.4.6.1. Company overview
                            10.4.6.2. Financial performance
                            10.4.6.3. Product benchmarking
                            10.4.6.4. Strategic initiatives
                        10.4.7. Charles River Laboratories
                            10.4.7.1. Company overview
                            10.4.7.2. Financial performance
                            10.4.7.3. Product benchmarking
                            10.4.7.4. Strategic initiatives
                        10.4.8. Eurofins Scientific
                            10.4.8.1. Company overview
                            10.4.8.2. Financial performance
                            10.4.8.3. Product benchmarking
                            10.4.8.4. Strategic initiatives
                        10.4.9. Lonza
                            10.4.9.1. Company overview
                            10.4.9.2. Financial performance
                            10.4.9.3. Product benchmarking
                            10.4.9.4. Strategic initiatives
                        10.4.10. Thermo Fisher Scientific, Inc.
                            10.4.10.1. Company overview
                            10.4.10.2. Financial performance
                            10.4.10.3. Product benchmarking
                            10.4.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Middle East Genome editing Market, By country, 2021 - 2033 (USD Million)
Table 5 Middle East Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 6 Middle East Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 7 Middle East Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 8 Middle East Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 9 Middle East Genome editing Market, By end use, 2021 - 2033 (USD Million)
Table 10 Saudi Arabia Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 11 Saudi Arabia Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 12 Saudi Arabia Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 13 Saudi Arabia Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 14 Saudi Arabia Genome editing Market, By end use, 2021 - 2033 (USD Million)
Table 15 UAE Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 16 UAE Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 17 UAE Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 18 UAE Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 19 UAE Genome editing Market, By end use, 2021 - 2033 (USD Million)
Table 20 Kuwait Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 21 Kuwait Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 22 Kuwait Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 23 Kuwait Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 24 Kuwait Genome editing Market, By end use, 2021 - 2033 (USD Million)
Table 25 Qatar Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 26 Qatar Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 27 Qatar Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 28 Qatar Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 29 Qatar Genome editing Market, By end use, 2021 - 2033 (USD Million)
Table 30 Oman Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 31 Oman Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 32 Oman Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 33 Oman Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 34 Oman Genome editing Market, By end use, 2021 - 2033 (USD Million)
Table 35 Rest of Middle East Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 36 Rest of Middle East Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 37 Rest of Middle East Genome editing Market, By applications, 2021 - 2033 (USD Million)
Table 38 Rest of Middle East Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 39 Rest of Middle East Genome editing Market, By end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Middle East genome editing market segmentation
Fig. 2 Information procurement
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market research process
Fig. 7 Information procurement
Fig. 8 Primary research
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Middle East genome editing market: Technology outlook key takeaways
Fig. 13 Middle East genome editing market: Technology movement analysis
Fig. 14 Middle East CRISPR/Cas9 market, 2021 - 2033 (USD Million)
Fig. 15 Middle East ZFN market, 2021 - 2033 (USD Million)
Fig. 16 Middle East meganuclease market, 2021 - 2033 (USD Million)
Fig. 17 Middle East others market, 2021 - 2033 (USD Million)
Fig. 18 Middle East genome editing market: Delivery Method outlook and key takeaways
Fig. 19 Middle East genome editing market: Delivery Method movement analysis
Fig. 20 Middle East ex vivo market, 2021 - 2033 (USD Million)
Fig. 21 Middle East in vivo market, 2021 - 2033 (USD Million)
Fig. 22 Middle East genome editing market: Application outlook and key takeaways
Fig. 23 Middle East genome editing market: Application movement analysis
Fig. 24 Middle East genetic engineering market, 2021 - 2033 (USD Million)
Fig. 25 Middle East cell line engineering market, 2021 - 2033 (USD Million)
Fig. 26 Middle East animal genetic engineering market, 2021 - 2033 (USD Million)
Fig. 27 Middle East plant genetic engineering market, 2021 - 2033 (USD Million)
Fig. 28 Middle East others market, 2021 - 2033 (USD Million)
Fig. 29 Middle East clinical applications market, 2021 - 2033 (USD Million)
Fig. 30 Middle East therapy development market, 2021 - 2033 (USD Million)
Fig. 31 Middle East diagnostics development market, 2021 - 2033 (USD Million)
Fig. 32 Middle East genome editing market: Mode outlook and key takeaways
Fig. 33 Middle East genome editing market: Mode movement analysis
Fig. 34 Middle East contract market, 2021 - 2033 (USD Million)
Fig. 35 Middle East in-house market, 2021 - 2033 (USD Million)
Fig. 36 Middle East genome editing market: End use outlook and key takeaways
Fig. 37 Middle East genome editing market: End use movement analysis
Fig. 38 Middle East biotechnology & pharmaceutical companies market, 2021 - 2033 (USD Million)
Fig. 39 Middle East academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 40 Middle East contract research organizations market, 2021 - 2033 (USD Million)
Fig. 41 Middle East genome editing market revenue, by country, 2022 & 2033 (USD Million)
Fig. 42 Country marketplace outlook, 2024 & 2033 (USD Million)
Fig. 43 Country marketplace: Key takeaways
Fig. 44 Key country dynamics
Fig. 45 Saudi Arabia genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 UAE genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Kuwait genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Key Country Dynamics
Fig. 51 Qatar genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Oman genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Rest of Middle East genome editing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Market participant categorization
Fig. 57 Strategic framework